Raffles Medical Group (SGX:BSL) FFO


SGX:BSL Raffles Medical Group Ltd SGX:BSL
86 GF Score
Price S$0.92
GF Value S$1.05
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Raffles Medical Group FFO?

FFO (Funds from operations) only applies to REITs.

SGX:BSL
86GF Score
Raffles Medical Group Ltd SGX:BSL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Raffles Medical Group (SGX:BSL) Overvalued in 2026?

Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued. The current stock price of S$0.92 is trading 12.9% below its estimated GF Value™ of S$1.05. GuruFocus considers Raffles Medical Group to be Modestly Undervalued.

Key valuation signals for SGX:BSL:

  • FFO:
  • GF Value™: S$1.05 vs. price of S$0.92 (12.9% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the SGX:BSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Raffles Medical Group Business Description

Other Exchanges RAFLF:USA
Address 585 North Bridge Road, No. 11-00, Raffles Hospital, Singapore, SGP, 188770
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
86GF Score

Get the complete analysis for SGX:BSL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.92
Price
S$1.05
GF Value